Polymorphism in KIF6 Gene and Benefit From Statins After Acute Coronary Syndromes: Results From the PROVE IT-TIMI 22 Study
- 29 January 2008
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 51 (4), 449-455
- https://doi.org/10.1016/j.jacc.2007.10.017
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Kinesin Family Member 6 Variant Is Associated With Coronary Heart Disease in the Women’s Health StudyJournal of the American College of Cardiology, 2008
- Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular DiseaseCirculation, 2007
- Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapyCurrent Opinion in Lipidology, 2007
- TCF7L2Polymorphisms and Progression to Diabetes in the Diabetes Prevention ProgramNew England Journal of Medicine, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseThe New England Journal of Medicine, 2006
- Statin pharmacogenomics: what have we learned, and what remains unanswered?Current Opinion in Lipidology, 2005
- The Case for Intensive Statin Therapy After Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- Genetic MarkersCirculation, 2004
- Beyond the LaboratoryCirculation, 2004
- Molecular Motor Proteins of the Kinesin Superfamily Proteins (KIFs): Structure, Cargo and DiseaseJournal of Korean Medical Science, 2004